from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3596c/clpC1

LFCtreatmentdescriptionclass of inhibitor

-1.715

Amikacinug/mL Amikacintranslation

-2.543

Cap5-10ug/mL Capreomycintranslation

-2.550

Rox10-50 ug/mL Roxithromycintranslation

0.456

SM2-5 ug/mL Streptomycintranslation

-3.054

Tet5-10 ug/mL Tetracyclinetranslation

-1.271

Rif0.2-5ug/mL Rifampicintranscription

-0.740

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.310

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.584

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.010

CPZ10-50 ug/mL Chlorpromazinerespiration

0.285

Clofazimine10-13 ug/mL Clofaziminerespiration

0.006

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.741

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.619

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.068

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.072

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.165

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.007

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.950

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.554

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.494

KCN5-20 ug/mL Potassium cyaniderespiration

-0.074

NaN30.2-2 mM Sodium aziderespiration

-0.407

Nigericin50 uM Nigericinrespiration

-0.887

TRC10-150 ug/mL Triclosanrespiration

0.821

TRZ10-25 ug/mL Thioridazinerespiration

0.017

Valinomycin0.5-10 uM Valinomycinrespiration

-0.261

ZnSO42 mM ZnSO4respiration

2.523

menadione6-10 ug/mL Menadionerespiration

-0.014

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.693

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.506

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.299

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.355

NRP_1Non-replicating persistence stage 1dosRassociated

0.114

Amp0.2mg/mL AmpicillincellWall

-0.096

Cephalexin20-100 ug/mL CephalexincellWall

-0.085

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.718

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.074

EMB10-20 ug/mL EthambutolcellWall

-0.374

Eta12-40 ug/mL EthionamidecellWall

-0.520

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.180

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.984

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.848

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.670

BZA0.12 mg/mL BenzamidearomaticAmides

0.432

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.587

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.072

H2O24 mM hydrogen peroxideDNAdamaging

-1.325

Levo10 ug/mL LevofloxacinDNAdamaging

-0.181

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.001

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.418

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.061

UVUV-irradiationDNAdamaging

0.963

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.315

Antimycin12.5-50 ug/mL Antimycin A?

-0.606

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.122

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.636

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.718

PA8240.2-2 ug/mL PA-824?

0.541

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.349

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.452

Verapamil50 uM Verapamil?

-0.505

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.300

methoxatin10-20 ug/mL Methoxatin?